Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
411. |
ECCT/12/12/01 | A pilot study to optimise controlled human malaria infections in humans with varying degrees of prior exposure to malaria using P. falciparum sporozoites administered by needle and syringe |
Principal Investigator(s) 1. Bernhards Ogutu 2. Kevin Marsh Site(s) in Kenya Kenya Medical Research Institute, Centre for Clinical Research, Nairobi |
18-01-2013 |
View |
412. |
ECCT/20/08/03 | NIH_PREFER Prebiotic galacto-oligosaccharides and lactoferrin for beneficial gut microbiota with iron supplements: an intervention trial in infants in Msambweni, Kwale County, southern coastal Kenya |
Principal Investigator(s) 1. Gary Brittenham Site(s) in Kenya Msambweni County Referral Hospital |
21-02-2021 |
View |
413. |
ECCT/16/02/01 | ASSESSING THE ACCURACY, USABILITY AND ACCEPTABILITY OF CHILDREN’S AUTOMATED RESPIRATORY MONITOR AT SELECTED CLINICS IN TURKANA COUNTY, KENYA ‘ ASSESSING THE ACCURACY, USABILITY AND ACCEPTABILITY OF CHILDREN’S AUTOMATED RESPIRATORY MONITOR AT SELECTED CLINICS IN TURKANA COUNTY, KENYA ‘ |
Principal Investigator(s) 1. ISAIAH MWANGI Site(s) in Kenya 1. lodwar hospital (Turkana county) |
21-03-2016 |
View |
414. |
ECCT/15/12/01 | A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY) Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya. |
Principal Investigator(s) 1. Prof Fabian Esamai Omoding Esamai Site(s) in Kenya 1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county) 2. Sirisia, Chwele, Bokoli (Bung\'oma county) 3. Makunga, Mumias (Kakamega county) |
16-02-2016 |
View |
415. |
ECCT/15/06/04 | A5316 A5316 Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy |
Principal Investigator(s) 1. Dr. Esther Mumbi Makanga Makanga 2. Dr. Victor Akelo Akelo 3. Dr.Victor O. Mudhune Mudhune 4. Dr. Kevin P. Cain Cain Site(s) in Kenya KEMRI- CDC |
17-07-2015 |
View |
416. |
ECCT/18/11/01 | PrIMA PrEP Implementation for Mothers in Antenatal Care |
Principal Investigator(s) 1. Grace John-Stewart John-Stewart 2. Jared Baeten Site(s) in Kenya 1. Homa Bay County - 10 sites (Homa Bay county) 2. Siaya County - 10 sites (Siaya county) |
16-05-2019 |
View |
417. |
ECCT/25/02/03 | NOZE20240219TB “Validation of a Digital Olfaction Based Breathalyzer Device for Non-Invasive Detection of Volatile Biomarkers in Patients with and without Tuberculosis: Case Control Study”. |
Principal Investigator(s) 1. Ibrahim Daud Site(s) in Kenya KEMRI/WRP CRC Kericho |
15-05-2025 |
View |
418. |
ECCT/22/03/08 | CVIA 092 “ A Phase 3 Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Safety (Ages 6 Months to 45 Years) and Non-inferiority (Ages 9-12 Months) of Multi-dose and Single-dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) against Typbar TCV® and Lot-to-Lot Consistency of the Immune Response (Ages 9-12 Months) to Multi-dose Vial Formulation EuTCV in Healthy African Participants”. |
Principal Investigator(s) 1. Dr Lucy Koech Chepkurui Koech Site(s) in Kenya KEMRI/ KERICHO CRC |
31-05-2022 |
View |
419. |
ECCT/26/06/03 | C1091009 - Study Site 1254 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Fredrick Kipyego Sawe Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project (Kericho county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
420. |
ECCT/15/01/02 | Study title An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya. Clinical Phase IV |
Principal Investigator(s) 1. Prof Walter Jaoko Jaoko Site(s) in Kenya KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR) |
10-03-2015 |
View |